Advantage Therapeutics, Inc.

Miami, FL Advantage Therapeutics Inc.

UEI
EBP3RA2ERYZ2
CAGE
25EL5
Primary NAICS
325411 Medicinal and Botanical Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
195 NW 40th St, Miami, FL 33127, USA
Website
advantagetherapeutics.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Advantage Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
AD04 disease-modifying drug for alzheimer's - preclinical and IND-enabling studies - project summary alzheimer's disease… Grant · R44AG091827 National Institute on Aging $3,749,282

Quick answers

What is Advantage Therapeutics, Inc.'s UEI?

Advantage Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is EBP3RA2ERYZ2.

What is Advantage Therapeutics, Inc.'s CAGE code?

Advantage Therapeutics, Inc.'s CAGE code is 25EL5.

What is Advantage Therapeutics, Inc.'s primary NAICS code?

Advantage Therapeutics, Inc.'s primary NAICS code is 325411 (Medicinal and Botanical Manufacturing).

Where is Advantage Therapeutics, Inc. located?

Advantage Therapeutics, Inc.'s physical address in SAM.gov is 195 NW 40th St, Miami, FL 33127, USA.

Is Advantage Therapeutics, Inc. registered in SAM.gov?

Yes. Advantage Therapeutics, Inc.'s SAM.gov registration is active through September 16, 2027.

What is Advantage Therapeutics, Inc.'s most recent federal award?

Advantage Therapeutics, Inc.'s most recent federal grant award is AD04 disease-modifying drug for alzheimer's - preclinical and IND-enabling studies - project summary alzheimer's disease… (R44AG091827), from National Institute on Aging, on September 20, 2025.

On GovTribe

See Advantage Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login